Replies to post #12355 on Sorrento Therapeutics Inc (SRNE)

[Brandywhitneylady]

$ 6.50

[1776club]

ooh, ooh...I'LL PLAY, I'll play. If the product is just COVISTIX then based on $6B in revenue and 400MM shares OS, I'd go to $60. Every $1B you add $10 to the share price. SCILEX spun off should add another $50 to the pile If ABIVERTINIB is looked at too be viable in 6 months then another $10 to $20 since I do not know what sales in China would be.

In short, $50 to $110 depending on revenue and projections.